Tag Archives: Tablets

FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis

FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis Print this page March 29, 2019 — The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease. Mavenclad is not recommended for MS patients with clinically isolated… Read More »

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Brain-Computer Interface Lets Users With Quadriplegia Control Tablets With Their Minds

Technology, Computer, Computer Monitor, Cloud Computing, Human BrainGetty New study points to remarkable outcomes for victims of paralysis. Most of us can’t imagine a day going by without interacting with a smartphone or tablet. For those with quadriplegia, though, this is an accepted reality. But new research from BrainGate — a collaboration among scientists, engineers… Read More »